{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:14:09Z","timestamp":1771870449708,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12094-012-0799-x","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T04:07:50Z","timestamp":1334549270000},"page":"302-311","source":"Crossref","is-referenced-by-count":31,"title":["Curcumin abrogates bile-induced NF-\u03baB activity and DNA damage in vitro and suppresses NF-\u03baB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett\u2019s oesophagus"],"prefix":"10.1007","volume":"14","author":[{"given":"Nihit","family":"Rawat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Alhamdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"McAdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zak","family":"Eltahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John N.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth J. S.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,17]]},"reference":[{"key":"799_CR1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/0016-5085(92)91510-B","volume":"103","author":"A.J. Cameron","year":"1992","unstructured":"Cameron AJ, Lomboy CT (1992) Barrett\u2019s oesophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 103:1241\u20131245","journal-title":"Gastroenterology"},{"key":"799_CR2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0140-6736(94)90349-2","volume":"344","author":"S.J. Spechler","year":"1994","unstructured":"Spechler SJ, Zeroogian JM, Antonioli DA et al (1994) Prevalence of metaplasia at the gastrooesophageal junction. Lancet 344:1533\u20131536","journal-title":"Lancet"},{"key":"799_CR3","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","volume":"129","author":"J. Ronkainen","year":"2005","unstructured":"Ronkainen J, Aro P, Storskrubb T et al (2005) Prevalence of Barrett\u2019s oesophagus in the general population: an endoscopic study. Gastroenterology 129:1825\u20131831","journal-title":"Gastroenterology"},{"key":"799_CR4","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(00)03411-5","volume":"356","author":"J.A. Jankowski","year":"2000","unstructured":"Jankowski JA, Harrison RF, Perry I et al (2000) Barrett\u2019s metaplasia. Lancet 356:2079\u20132085","journal-title":"Lancet"},{"key":"799_CR5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrc1166","volume":"3","author":"C.P. Wild","year":"2003","unstructured":"Wild CP, Hardie LJ (2003) Reflux, Barrett\u2019s oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 3:676\u2013684","journal-title":"Nat Rev Cancer"},{"key":"799_CR6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.sla.0000118751.95179.c6","volume":"239","author":"M.M. Abdel-Latif","year":"2004","unstructured":"Abdel-Latif MM, O\u2019Riordan J, Windle HJ et al (2004) NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett\u2019s metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 239:491\u2013500","journal-title":"Ann Surg"},{"key":"799_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/carcin\/bgh032","volume":"25","author":"G.J. Jenkins","year":"2004","unstructured":"Jenkins GJ, Harries K, Doak SH et al (2004) The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis 25: 317\u2013323","journal-title":"Carcinogenesis"},{"key":"799_CR8","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","volume":"18","author":"B. Rayet","year":"1999","unstructured":"Rayet B, Gelinas C (1999) Aberrant rel\/nfkb genes and activity in human cancer. Oncogene 18:6938\u20136947","journal-title":"Oncogene"},{"key":"799_CR9","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1038\/sj.onc.1206390","volume":"22","author":"A. Arlt","year":"2003","unstructured":"Arlt A, Gehrz A, Muerkoster S et al (2003) Role of NF-kappaB and Akt\/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22:3243\u20133251","journal-title":"Oncogene"},{"key":"799_CR10","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1158\/0008-5472.CAN-06-4257","volume":"67","author":"A.B. Kunnumakkara","year":"2007","unstructured":"Kunnumakkara AB, Guha S, Krishnan S et al (2007) Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67: 3853\u20133861","journal-title":"Cancer Res"},{"key":"799_CR11","first-page":"503","volume":"111","author":"S.E. Attwood","year":"1992","unstructured":"Attwood SE, Smyrk TC, DeMeester TR et al (1992) Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 111:503\u2013510","journal-title":"Surgery"},{"key":"799_CR12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/bjs.1800750612","volume":"75","author":"P. Gillen","year":"1988","unstructured":"Gillen P, Keeling P, Byrne PJ et al (1988) Implication of duodenogastric reflux in the pathogenesis of Barrett\u2019s oesophagus. Br J Surg 75:540\u2013543","journal-title":"Br J Surg"},{"key":"799_CR13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/gut.52.2.174","volume":"52","author":"C. Tselepis","year":"2003","unstructured":"Tselepis C, Morris CD, Wakelin D et al (2003) Upregulation of the oncogene c-myc in Barrett\u2019s adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 52:174\u2013180","journal-title":"Gut"},{"key":"799_CR14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/carcin\/bgl147","volume":"28","author":"G.J. Jenkins","year":"2007","unstructured":"Jenkins GJ, D\u2019souza FR, Suzen SH et al (2007) Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: The potential role of anti-oxidants in Barrett\u2019s oesophagus. Carcinogenesis 28:136\u2013142","journal-title":"Carcinogenesis"},{"key":"799_CR15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/mutage\/gen029","volume":"23","author":"G.J. Jenkins","year":"2008","unstructured":"Jenkins GJ, Cronin J, Alhamdani A et al (2008) The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS. Mutagenesis 23:399\u2013405","journal-title":"Mutagenesis"},{"key":"799_CR16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.20160","volume":"111","author":"J. Odot","year":"2004","unstructured":"Odot J, Albert P, Carlier A et al (2004) In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int J Cancer 111:381\u2013387","journal-title":"Int J Cancer"},{"key":"799_CR17","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","volume":"14","author":"N. Dhillon","year":"2008","unstructured":"Dhillon N, Aggarwal BB, Newman RA et al (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14: 4491\u20134499","journal-title":"Clin Cancer Res"},{"key":"799_CR18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0027-5107(94)90183-X","volume":"311","author":"M. Subramanian","year":"1994","unstructured":"Subramanian M, Sreejayan, Rao MN et al (1994) Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. Mutat Res 311:249\u2013255","journal-title":"Mutat Res"},{"key":"799_CR19","first-page":"813","volume":"51","author":"M.T. Huang","year":"1991","unstructured":"Huang MT, Lysz T, Ferraro T et al (1991) Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51:813\u2013819","journal-title":"Cancer Res"},{"key":"799_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2004.03.015","volume":"68","author":"X. Gao","year":"2004","unstructured":"Gao X, Kuo J, Jiang H et al (2004) Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 68:51\u201361","journal-title":"Biochem Pharmacol"},{"key":"799_CR21","first-page":"321","volume":"24","author":"S. Baatout","year":"2004","unstructured":"Baatout S, Derradji H, Jacquet P et al (2004) Effect of curcuma on radiation-induced apoptosis in human cancer cells. Int J Oncol 24:321\u2013329","journal-title":"Int J Oncol"},{"key":"799_CR22","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/cncr.21904","volume":"106","author":"Z. Wang","year":"2006","unstructured":"Wang Z, Zhang Y, Banerjee S et al (2006) Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 106: 2503\u20132513","journal-title":"Cancer"},{"key":"799_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10408690490424702","volume":"44","author":"B. Joe","year":"2004","unstructured":"Joe B, Vijaykumar M, Lokesh BR (2004) Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44:97\u2013111","journal-title":"Crit Rev Food Sci Nutr"},{"key":"799_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-8741(98)00234-7","volume":"67","author":"D. Eigner","year":"1999","unstructured":"Eigner D, Scholz D (1999) Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J Ethnopharmacol 67:1\u20136","journal-title":"J Ethnopharmacol"},{"key":"799_CR25","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1158\/1078-0432.CCR-07-4722","volume":"14","author":"A.B. Kunnumakkara","year":"2008","unstructured":"Kunnumakkara AB, Diagaradjane P, Guha S et al (2008) Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin Cancer Res 14:2128\u20132136","journal-title":"Clin Cancer Res"},{"key":"799_CR26","first-page":"1281","volume":"26","author":"C.C. Su","year":"2006","unstructured":"Su CC, Chen GW, Lin JG et al (2006) Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B \/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res 26:1281\u20131288","journal-title":"Anticancer Res"},{"key":"799_CR27","first-page":"363","volume":"23","author":"B.B. Aggarwal","year":"2003","unstructured":"Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363\u2013398","journal-title":"Anticancer Res"},{"key":"799_CR28","first-page":"118","volume":"18","author":"K.M. Mohandas","year":"1999","unstructured":"Mohandas KM, Desai DC (1999) Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J Gastroenterol 18:118\u2013121","journal-title":"Indian J Gastroenterol"},{"key":"799_CR29","first-page":"431","volume":"41","author":"A.D. Amarapurkar","year":"1998","unstructured":"Amarapurkar AD, Vora IM, Dhawan PS (1998) Barrett\u2019s oesophagus. Indian J Pathol Microbiol 41:431\u2013435","journal-title":"Indian J Pathol Microbiol"},{"key":"799_CR30","first-page":"144","volume":"20","author":"P.S. Dhawan","year":"2001","unstructured":"Dhawan PS, Alvares JF, Vora IM et al (2001) Prevalence of short segments of specialized columnar epithelium in distal oesophagus: association with gastroesophageal reflux. Indian J Gastroenterol 20:144\u2013147","journal-title":"Indian J Gastroenterol"},{"key":"799_CR31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0027-5107(00)00065-8","volume":"455","author":"M. Fenech","year":"2000","unstructured":"Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455:81\u201395","journal-title":"Mutat Res"},{"key":"799_CR32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/gut.44.5.598","volume":"44","author":"D. Nehra","year":"1999","unstructured":"Nehra D, Howell P, Williams CP et al (1999) Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 44:598\u2013602","journal-title":"Gut"},{"key":"799_CR33","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/jcp.2006.043976","volume":"60","author":"G.J. Jenkins","year":"2007","unstructured":"Jenkins GJ, Mikhail J, Alhamdani A et al (2007) Immunohistochemical study of nuclear factorkappaB activity and interleukin-8 abundance in oesophageal adenocarcinoma; a useful strategy for monitoring these biomarkers. J Clin Pathol 60:1232\u20131237","journal-title":"J Clin Pathol"},{"key":"799_CR34","first-page":"273","volume":"36","author":"K.B. Soni","year":"1992","unstructured":"Soni KB, Kuttan R (1992) Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 36:273\u2013275","journal-title":"Indian J Physiol Pharmacol"},{"key":"799_CR35","first-page":"2895","volume":"21","author":"A.L. Cheng","year":"2001","unstructured":"Cheng AL, Hsu CH, Lin JK et al (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895\u20132900","journal-title":"Anticancer Res"},{"key":"799_CR36","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","volume":"10","author":"R.A. Sharma","year":"2004","unstructured":"Sharma RA, Euden SA, Platton SL et al (2004) Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10:6847\u20136854","journal-title":"Clin Cancer Res"},{"key":"799_CR37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6882-6-10","volume":"6","author":"C.D. Lao","year":"2006","unstructured":"Lao CD, Ruffin MTt, Normolle D et al (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:10","journal-title":"BMC Complement Altern Med"},{"key":"799_CR38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0002-9610(99)80014-2","volume":"170","author":"G.J. Wetscher","year":"1995","unstructured":"Wetscher GJ, Hinder RA, Bagchi D et al (1995) Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 170:552\u2013556; discussion 6\u20137","journal-title":"Am J Surg"},{"key":"799_CR39","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1365-2036.2003.01734.x","volume":"18","author":"L. Liu","year":"2003","unstructured":"Liu L, Ergun G, Ertan A et al (2003) Detection of oxidative DNA damage in oesophageal biopsies of patients with reflux symptoms and normal pH monitoring. Aliment Pharmacol Ther 18:693\u2013698","journal-title":"Aliment Pharmacol Ther"},{"key":"799_CR40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<300::AID-IJC6>3.0.CO;2-5","volume":"68","author":"A. Tzonou","year":"1996","unstructured":"Tzonou A, Lipworth L, Garidou A et al (1996) Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer 68:300\u2013304","journal-title":"Int J Cancer"},{"key":"799_CR41","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/1097-0215(20000901)87:5<750::AID-IJC19>3.0.CO;2-6","volume":"87","author":"P. Terry","year":"2000","unstructured":"Terry P, Lagergren J, Ye W et al (2000) Antioxidants and cancers of the oesophagus and gastric cardia. Int J Cancer 87:750\u2013754","journal-title":"Int J Cancer"},{"key":"799_CR42","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.8096091","volume":"259","author":"S.C. Sun","year":"1993","unstructured":"Sun SC, Ganchi PA, Ballard DW et al (1993) NFkappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259:1912\u20131915","journal-title":"Science"},{"key":"799_CR43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3727\/096504001108747567","volume":"12","author":"L. Xu","year":"2000","unstructured":"Xu L, Fidler IJ (2000) Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol Res 12:97\u2013106","journal-title":"Oncol Res"},{"key":"799_CR44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1006\/cyto.1999.0614","volume":"12","author":"E. Lazar-Molnar","year":"2000","unstructured":"Lazar-Molnar E, Hegyesi H, Toth S et al (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12:547\u2013554","journal-title":"Cytokine"},{"key":"799_CR45","first-page":"5334","volume":"60","author":"S. Huang","year":"2000","unstructured":"Huang S, Robinson JB, Deguzman A et al (2000) Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60:5334\u20135339","journal-title":"Cancer Res"},{"key":"799_CR46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jlb.56.5.559","volume":"56","author":"A. Harada","year":"1994","unstructured":"Harada A, Sekido N, Akahoshi T et al (1994) Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56:559\u2013564","journal-title":"J Leukoc Biol"},{"key":"799_CR47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/cncr.10812","volume":"95","author":"H. Hidaka","year":"2002","unstructured":"Hidaka H, Ishiko T, Furuhashi T et al (2002) Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95:1206\u20131214","journal-title":"Cancer"},{"key":"799_CR48","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2005.41338.x","volume":"100","author":"J.M. O\u2019Riordan","year":"2005","unstructured":"O\u2019Riordan JM, Abdel-latif MM, Ravi N et al (2005) Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the oesophagus. Am J Gastroenterol 100:1257\u20131264","journal-title":"Am J Gastroenterol"},{"key":"799_CR49","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1023\/B:DDAS.0000037790.11724.70","volume":"49","author":"P.C. Konturek","year":"2004","unstructured":"Konturek PC, Nikiforuk A, Kania J et al (2004) Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett\u2019s oesophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Dig Dis Sci 49:1075\u20131083","journal-title":"Dig Dis Sci"},{"key":"799_CR50","doi-asserted-by":"crossref","first-page":"G388","DOI":"10.1152\/ajpgi.90428.2008","volume":"296","author":"P. Rafiee","year":"2009","unstructured":"Rafiee P, Nelson VM, Manley S et al (2009) Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): role of PKC, MAPKs, and NFkappaB. Am J Physiol Gastrointest Liver Physiol 296:G388\u2013398","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"799_CR51","first-page":"209","volume":"28","author":"C. Freudlsperger","year":"2008","unstructured":"Freudlsperger C, Greten J, Schumacher U (2008) Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NFkappaB. Anticancer Res 28:209\u2013214","journal-title":"Anticancer Res"},{"key":"799_CR52","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/carcin\/bgh233","volume":"25","author":"G.P. Collett","year":"2004","unstructured":"Collett GP, Campbell FC (2004) Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25:2183\u20132189","journal-title":"Carcinogenesis"},{"key":"799_CR53","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bcp.2008.07.031","volume":"76","author":"S. Reuter","year":"2008","unstructured":"Reuter S, Eifes S, Dicato M et al (2008) Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76:1340\u20131351","journal-title":"Biochem Pharmacol"},{"key":"799_CR54","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/hupa.2002.124908","volume":"33","author":"C.J. Woude van der","year":"2002","unstructured":"van der Woude CJ, Jansen PL, Tiebosch AT et al (2002) Expression of apoptosis-related proteins in Barrett\u2019s metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype. Hum Pathol 33:686\u2013692","journal-title":"Hum Pathol"},{"key":"799_CR55","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/S0046-8177(03)00354-X","volume":"34","author":"S. Iravani","year":"2003","unstructured":"Iravani S, Zhang HQ, Yuan ZQ et al (2003) Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett\u2019s neoplasia. Hum Pathol 34:975\u2013982","journal-title":"Hum Pathol"},{"key":"799_CR56","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/0008-5472.CAN-08-3703","volume":"69","author":"K. Hormi-Carver","year":"2009","unstructured":"Hormi-Carver K, Zhang X, Zhang HY et al (2009) Unlike esophageal squamous cells, Barrett\u2019s epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway. Cancer Res 69: 672\u2013677","journal-title":"Cancer Res"},{"key":"799_CR57","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<535::AID-PATH302>3.0.CO;2-G","volume":"187","author":"C.E. Whittles","year":"1999","unstructured":"Whittles CE, Biddlestone LR, Burton A et al (1999) Apoptotic and proliferative activity in the neoplastic progression of Barrett\u2019s oesophagus: a comparative study. J Pathol 187:535\u2013540","journal-title":"J Pathol"},{"key":"799_CR58","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/sj.bjc.6605308","volume":"101","author":"G. O\u2019sullivan-Coyne","year":"2009","unstructured":"O\u2019sullivan-Coyne G, O\u2019sullivan GC, O\u2019Donovan TR et al (2009) Curcumin induces apoptosisindependent death in oesophageal cancer cells. Br J Cancer 101:1585\u20131595","journal-title":"Br J Cancer"},{"key":"799_CR59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1593\/tlo.09235","volume":"3","author":"W. Hartojo","year":"2010","unstructured":"Hartojo W, Silvers AL, Thomas DG et al (2010) Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl Oncol 3:99\u2013108","journal-title":"Transl Oncol"},{"key":"799_CR60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/aje\/kwi218","volume":"162","author":"A.C. Ford","year":"2005","unstructured":"Ford AC, Forman D, Reynolds PD et al (2005) Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett\u2019s oesophagus. Am J Epidemiol 162:454\u2013460","journal-title":"Am J Epidemiol"},{"key":"799_CR61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-3155-5-3","volume":"5","author":"S. Bisht","year":"2007","unstructured":"Bisht S, Feldmann G, Soni S et al (2007) Polymeric nanoparticle-encapsulated curcumin (\u201cnanocurcumin\u201d): a novel strategy for human cancer therapy. J Nanobiotechnol 5:3","journal-title":"J Nanobiotechnol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0799-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0799-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0799-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T10:04:57Z","timestamp":1561629897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0799-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["799"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0799-x","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}